HYDERABAD, India and PRINCETON, N.J. — Dr. Reddy’s Laboratories announced Friday the U.S. launch of its generic of Wellbutrin SR (bupropion HCl) extended-release tablets.
Brand and generic sales of the drug were $109.6 million for the 12 months ended July 2016, according to IMS Health. The Dr. Reddy’s generic will be available in 60-, 100- and 500-count bottles in 100-, 150- and 200-mg dosage strengths.